Status:
UNKNOWN
Heart Patch for Myocardial Infarction COVID-19
Lead Sponsor:
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Collaborating Sponsors:
Fakultas Kedokteran Universitas Indonesia
RSUPN dr. Cipto Mangunkusumo
Conditions:
Myocardial Infarction
Heart Diseases
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
Myocardial infarction (MI), as one of the many complications of COVID-19, is one of the contributing patients of patients' death. This study attempts on developing an intervention of MI by regeneratin...
Eligibility Criteria
Inclusion
- Aged 40 - 60 years old
- Ischemic burden \>10% and ischemic gradients red-violet
- Ischemic area is not feasible to be grafted (bypass) due to other conditions such as diffusion and deep intramuscular vascularization
- Ejection fraction \>30-35%
- Euro score \<8
Exclusion
- Scanning of Technetium-99 showed black colored ischemic area
- Patients undergoing other procedures other than bypass such as valve repair
- Chronic kidney failure
- Patients have went through several bypass surgeries prior
- Patients are still COVID-19 positive
- Immunocompromised patients
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04728906
Start Date
April 1 2022
End Date
September 1 2022
Last Update
March 2 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
RSUPN dr. Cipto Mangunkusumo
Jakarta, DKI Jakarta, Indonesia, 10430
2
Rumah Sakit Universitas Indonesia
Depok, West Java, Indonesia, 16424
3
Pusat Jantung Nasional Harapan Kita
Jakarta, Indonesia, 11420